Relationship between pan-immune- inflammation value and in major cardiovascular and cerebrovascular events in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft surgery
- PMID: 38632613
- PMCID: PMC11022406
- DOI: 10.1186/s13019-024-02691-1
Relationship between pan-immune- inflammation value and in major cardiovascular and cerebrovascular events in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft surgery
Abstract
Background: In this study, we aimed to evaluate the association of pan-immune-inflammation value (PIV) with major cardiovascular and cerebrovascular events (MACCE) in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft (CABG) surgery.
Methods: We retrospectively analyzed data from 527 patients who underwent on-pump CABG surgery for stable coronary artery disease between June 2015 and December 2020. Patients were categorized into two groups based on MACCE development. PIV levels were calculated from blood samples taken on admission. PIV was calculated as [neutrophil count (×103/µL)×platelet count (×103/µL))×monocyte count (×103/µL)]/lymphocyte count (×103/µL). The primary endpoint was long-term major cardiovascular and cerebrovascular events (MACCE) at a median follow-up of 4.6 years.
Results: Of the included patients, 103 (19.5%) developed MACCE. PIV was higher in patients with MACCE compared to those without (470.8 [295.3-606.8] vs. 269.8 [184.3-386.4], p < 0.001). Multivariate analysis showed a significant positive association between PIV and MACCE (HR: 1.326, 95%CI:1.212-1452, p < 0.001). The cut-off value for the PIV in the estimation of MACCE was 368.28 ( AUC: 0.726 with 69% sensitivity, 71% specificity, p < 0.001).
Conclusion: This study shows a significant link between high PIV levels and MACCE in stable coronary artery disease patients undergoing on-pump CABG surgery. Our findings suggest that PIV may be a valuable, routinely available, and inexpensive marker for identifying patients at increased risk of MACCE.
Keywords: Coronary artery bypass graft; Major cardiovascular and cerebrovascular events; Pan-immune-inflammation value; Stable coronary artery disease.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.Ir J Med Sci. 2021 Feb;190(1):89-96. doi: 10.1007/s11845-020-02257-9. Epub 2020 Jun 12. Ir J Med Sci. 2021. PMID: 32529544
-
Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.Cardiovasc Diabetol. 2023 Oct 27;22(1):286. doi: 10.1186/s12933-023-02029-6. Cardiovasc Diabetol. 2023. PMID: 37891647 Free PMC article.
-
Predictive Value of Neutrophil-Lymphocyte Ratio for Long-Term Cardiovascular Event Following Coronary Artery Bypass Grafting.Braz J Cardiovasc Surg. 2020 Jun 1;35(3):274-284. doi: 10.21470/1678-9741-2018-0362. Braz J Cardiovasc Surg. 2020. PMID: 32549098 Free PMC article.
-
Cardiovascular Risk Profile, Presentation and Management Outcomes of Patients with Acute Coronary Syndromes after Coronary Artery Bypass Grafting.Curr Probl Cardiol. 2022 Nov;47(11):101078. doi: 10.1016/j.cpcardiol.2021.101078. Epub 2021 Dec 11. Curr Probl Cardiol. 2022. PMID: 34902394 Review.
-
Meta-analysis study comparing percutaneous coronary intervention/drug eluting stent versus coronary artery bypass surgery of unprotected left main coronary artery disease: Clinical outcomes during short-term versus long-term (> 1 year) follow-up.Medicine (Baltimore). 2018 Feb;97(7):e9909. doi: 10.1097/MD.0000000000009909. Medicine (Baltimore). 2018. PMID: 29443766 Free PMC article.
Cited by
-
Association of RDW-Albumin Ratio, TG-Glucose Index, and PIV with Coronary Artery Disease.J Clin Med. 2024 Nov 21;13(23):7003. doi: 10.3390/jcm13237003. J Clin Med. 2024. PMID: 39685462 Free PMC article.
-
The Role of Triglyceride/HDL Ratio, Triglyceride-Glucose Index, and Pan-Immune-Inflammation Value in the Differential Diagnosis of Acute Coronary Syndrome and Predicting Mortality.J Clin Med. 2024 Aug 16;13(16):4832. doi: 10.3390/jcm13164832. J Clin Med. 2024. PMID: 39200973 Free PMC article.
-
Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride-Glucose Index and Pan-Immune Inflammation Value.J Clin Med. 2024 Oct 9;13(19):6008. doi: 10.3390/jcm13196008. J Clin Med. 2024. PMID: 39408068 Free PMC article.
-
The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery-Exploring the Molecular Connections.Int J Mol Sci. 2024 Oct 10;25(20):10891. doi: 10.3390/ijms252010891. Int J Mol Sci. 2024. PMID: 39456673 Free PMC article. Review.
References
-
- Hamada Y, Kawachi K, Yamamoto T, et al. Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts. J Cardiovasc Surg. 2001;42(2):159–64. - PubMed
-
- Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–38. doi: 10.1016/S0140-6736(13)60141-5. - DOI - PubMed
-
- Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46(4):575–81. doi: 10.1016/j.jacc.2004.12.082. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical